Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register
      S&P 500
      4,266.91
      (
      -0.49%
      )
      US Tech 100
      14,375.20
      (
      0.31%
      )
      Dow Jones
      33,313.89
      (
      -0.58%
      )
      Brent Oil
      90.275
      (
      -1.89%
      )
      Bitcoin
      28,002.43
      (
      0.05%
      )
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Merck and Co Inc (MRK)

      7. Merck and Co Inc (MRK) News

      MRK Merck and Co Inc

      101.92
      -1.03 (-1.0%)
      Last Updated: 14:22:21
      Delayed by 15 minutes

      Register Free for Streaming Quotes & Tools

      Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.

      Register
      Company Name Stock Ticker Symbol Market Type
      Merck and Co Inc MRK NYSE Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      -1.03 -1.0% 101.92 14:22:21
      Open Price Low Price High Price Close Price Prev Close
      102.97 101.35 102.97 102.95
      more quote information »

      Recent News

      Date Time Source Heading
      9/28/202307:41DJNMerck Gets FDA Priority Review of Sotatercept in Pulmonary..
      9/28/202306:45BWMerck Receives Priority Review from FDA for New Biologics..
      9/27/202313:11DJNMerck Currently Down Seven Consecutive Days, on Pace for..
      9/26/202307:34IHMARKETNEWSTuesday’s Wall Street Highlights: Ford Motor, Coty,..
      9/22/202307:46DJNMerck, Eisai: Keytruda/Lenvima Combo Fails in Two Non-Small..
      9/22/202307:02DJNMerck, Seagen, Astellas Phase 3 Bladder Cancer Study Hits..
      9/22/202306:45BWMerck and Eisai Provide Update on Two Phase 3 Trials..
      9/22/202306:00BWMerck Announces Phase 3 KEYNOTE-A39/EV-302 Trial Met Dual..
      9/20/202307:42DJNMerck Gets FDA Priority Review for New Keytruda Cervical..
      9/20/202306:45BWFDA Grants Priority Review to Merck’s Application for..
      9/19/202307:27DJNMerck Gets FDA Priority Review of Welireg in Advanced Renal..
      9/19/202306:45BWFDA Accepts for Priority Review Merck’s Supplemental New..
      9/15/202310:03DJNMerck Gets CHMP Backing for Keytruda as Non-Small Cell Lung..
      9/15/202309:10BWMerck Receives Positive EU CHMP Opinion for KEYTRUDA®..
      9/11/202307:45BWMerck Presents New Analyses Supporting the Promising..
      9/07/202306:45BWEuropean Commission Expands Merck’s ERVEBO® [Ebola Zaire..
      9/05/202309:08DJNMerck: Gardasil 9 Long-Term Followup Study Finds No Serious..
      9/05/202308:51DJNPortage Biotech in Keytruda Collaboration With Merck
      9/05/202308:00BWLong-Term Follow-up Data on Sustained Immunogenicity and..
      9/05/202306:45BWMerck to Participate in the Morgan Stanley 21st Annual..
      8/29/202306:50BWEuropean Commission Approves KEYTRUDA® (pembrolizumab) Plus..
      8/29/202306:45BWMerck to Participate in the Citi 18th Annual BioPharma..
      8/25/202309:11DJNCorrection to Merck, Eisai: Keytruda/Lenvima Combo Article
      8/25/202307:25DJNMerck Launches Phase 3 for MK-0616 Oral Cholesterol Drug
      8/25/202307:09DJNMerck, Eisai: Keytruda/Lenvima Combo Fails in Head, Neck..
      8/25/202306:30BWMerck Initiates Phase 3 Clinical Program for Oral PCSK9..
      8/25/202306:15BWMerck and Eisai Provide Update on Phase 3 LEAP-010 Trial..
      8/24/202306:45BWLYNPARZA® (olaparib) Plus Abiraterone and Prednisone or..
      8/23/202310:32DJNMerck on Pace for Largest Percent Increase Since April 2022..
      8/18/202307:41DJNMerck Phase 3 Welireg Study Hits Key Endpoint in Renal Cell..
      8/18/202306:45BWMerck Announces WELIREG® (belzutifan) Phase 3 LITESPARK-005..
      8/15/202316:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/14/202316:13EDGAR2Form 144 - Report of proposed sale of securities
      8/07/202316:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      8/07/202308:30PRNUSAnixa Biosciences Announces Opening of Enrollment for..
      8/04/202316:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/04/202316:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/03/202316:12EDGAR2Form 144 - Report of proposed sale of securities
      8/03/202316:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/03/202307:33IHMARKETNEWSThursday’s Wall Street Highlights: Anheuser-Busch InBev,..
      8/03/202306:45BWU.S. FDA Approves Merck’s ERVEBO® (Ebola Zaire Vaccine,..
      8/02/202307:59IHMARKETNEWSWednesday’s Wall Street Highlights: CVS Health, Starbucks,..
      8/01/202310:06DJNTrending: Merck Posts Narrower-Than-Expected 2Q Loss
      8/01/202306:46EDGAR2Form 8-K - Current report
      8/01/202306:30BWMerck Announces Second-Quarter 2023 Financial Results
      7/28/202307:54DJNMerck Phase 3 Keytruda Study Hits Key Goal in Early..
      7/28/202306:45BWMerck Announces Phase 3 KEYNOTE-756 Trial Met Primary..
      7/27/202306:45BWMerck Announces V116, an Investigational, 21-valent..
      7/26/202306:45BWMerck and Moderna Initiate Phase 3 Study Evaluating V940..
      7/25/202312:58BWMerck Announces Fourth-Quarter 2023 Dividend
      Your Recent History
      NYSE
      MRK
      Merck
      Register now to watch these stocks streaming on the ADVFN Monitor.

      Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

      Log in to InvestorsHub
      Register Now